Ann: Notice of Extraordinary General Meeting/Proxy Form, page-27

I dont know. Retail haven't taken their eligible allotment of shares in CRs gone past. Do you want PH to pay for them and just hand them out? Or would you prefer that the money is just allowed to run out and the pipeline stop? At least your loss then wouldn't be dilution, would that make you happier?

This is a high risk investment. Its a prerevenue BIotech. Its potential its all about its pipeline. And this pipeline is novel, cutting edge and addressing unmet needs. There is zero EV value in the share price at the moment.

As I said, even 100% dilution gives a market cap of $46 million Australian pesos. Is that market cap good value when compared to 3 soon to be 4 trials hitting arms? Even with the dilution there is potential for many bags to be made. But the coffers will be full, and the pipeline potential can be realised.